Elios Therapeutics - Crunchbase Company Profile & Funding

Overview

Elios Therapeutics

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Elios Therapeutics

CB Rank

341321

Elios Therapeutics is a biopharmaceutical company.

Founded

obfuscation

Private

Austin, Texas, United States

1-10

www.eliostherapeutics.com/

Biotechnology

Pharmaceutical

Key People

Buddy Long: Chief Executive Officer

Details

Legal Name

ELIOS THERAPEUTICS, LLC

Operating Status

Active

Company Type

For Profit

About the Company

Elios Therapeutics is a biopharmaceutical company developing a portfolio of innovative therapeutic cancer vaccines targeting unmet medical needs across a broad range of tumor types. Elios’ lead product, TLPLDC, is a personalized therapeutic cancer vaccine designed to attack cancer cells by igniting innate and adaptive immune responses which

increase a patient’s own production of T cells to fight their specific cancer.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Tumor Lysate, Particle Only (TLPO) vaccine

A personalized therapeutic cancer vaccine that stimulates the immune system to recognize and attack tumor cells specific to a patient's cancer.

Tumor Lysate, Particle-Loaded Dendritic Cell (TLPLDC) vaccine

An autologous personalized cancer vaccine that uses dendritic cells loaded with tumor lysate particles to stimulate immune responses against a patient's tumor cells.